Suresh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.31 M
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 25.28%
- Profit Growth 6.64%
- Ebitda 49.96%
- Net Worth 4.79%
- Total Assets 3.89%
About Suresh Pharmaceuticals
Suresh Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 July 1986 and has a history of 38 years and seven months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.31 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Ranka, Premchand Ranka, Suresh Ranka, and One other member serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1986PTC013172
- Company No.
013172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Suresh Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sampathraj Ranka  | Director | 08-Jul-1986 | Current |
| Suresh Ranka | Director | 08-Jul-1986 | Current |
| Ashok Ranka | Director | 08-Jul-1986 | Current |
| Premchand Ranka | Director | 08-Jul-1986 | Current |
Financial Performance of Suresh Pharmaceuticals.
Suresh Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.28% increase. The company also saw a slight improvement in profitability, with a 6.64% increase in profit. The company's net worth moved up by a moderate rise of 4.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suresh Pharmaceuticals?
In 2022, Suresh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suresh Pharmaceuticals?
Unlock and access historical data on people associated with Suresh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suresh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suresh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.